The clinical relevance of axillary reverse mapping (ARM) - Clinical relevance of ARM

Amphia Ziekenhuis0 个研究点目标入组 280 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Female mental competent patients of at least 18 years of age with the diagnosis invasive breast cancer with an indication for a complementary axillary lymph node dissection (ALND) based on a positive sentinel lymph node (SLN) are eligible for an ALND-ARM procedure. The indication for a complementary ALND will be made in a multidisciplinary team including an oncologic surgeon, medical oncologist, pathologist, radiologist and a radiotherapist.

•Exclusion criteria are: primary ALND based on a clinical positive axilla (proven by cytological punction), a contra-indication for sentinel lymph node biopsy (SLNB), a history of breast-cancer, adverse event during the previous SLNB, pregnancy.
•Patients excluded for randomization between ALND and ALND-ARM will be possible candidates for the side study in which the feasibility of ARM (without sparing lymphatics and lymph nodes) is investigated.

发起方

Amphia Ziekenhuis